Skip to main content
Lynda Chin, MD, Dermatology, Boston, MA

LyndaChinMD

Dermatology Boston, MA

Professor of Dermatology, Brigham and Women's Hospital

Are you Dr. Chin?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 38 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Lynda Chin, MD is a dermatologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts and New York. She is a Professor of Dermatology at Brigham and Women's Hospital.

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Dermatology, 1994 - 1997
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1993 - 1994
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1993

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1995 - 2024
  • MA State Medical License
    MA State Medical License 2000 - 2013

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2004

Publications & Presentations

PubMed

Authored Content

  • Convening a Digitally Enabled Ecosystem to Address the Chronic Disease Burden of an Underserved CommunitySeptember 2018

Press Mentions

  • Health Gorilla and Apricity Health Join Forces to Improve Patient Care, Oncology Services
    Health Gorilla and Apricity Health Join Forces to Improve Patient Care, Oncology ServicesJune 1st, 2022
  • Elsevier Launches 'AI and Big Data in Cancer,' a New Conference on the Translation of Technology, Data and Analytic Innovations into Clinical Practices and Patient Benefits
    Elsevier Launches 'AI and Big Data in Cancer,' a New Conference on the Translation of Technology, Data and Analytic Innovations into Clinical Practices and Patient BenefitsJanuary 22nd, 2020
  • Pear Therapeutics Announces Collaboration with Apricity Health to Advance Prescription Digital Therapeutics to Be Prescribed in Combination with Immuno-Oncology Therapy
    Pear Therapeutics Announces Collaboration with Apricity Health to Advance Prescription Digital Therapeutics to Be Prescribed in Combination with Immuno-Oncology TherapyJanuary 13th, 2020
  • Join now to see all